10
2022Lucid Group
AGENCY STATEMENT
Founded in 2007, Lucid Group is a global healthcare consultancy who help clients to realise the full potential of their medicines. Experts in seamlessly combining commercial & medical strategy, creative & brand strategy, healthcare communications to solve healthcare's most complex problems.

- Agency description
Founded in 2007, Lucid Group is a global healthcare consultancy who help clients to realise the full potential of their medicines.
The unforgiving pace of specialised drug development, increasing market and stakeholder complexities, and unprecedented competition are combining to create the most challenging environment to launch and optimise new medicines.
We need solutions that arerevolutionary, not just incremental. Our solutions help our clients to:
- Discover meaningful, actionable insights that bring competitive advantagein real time
- Generate evidence to meet diverse stakeholder needs andfulfil the asset’s full potential
- Bring assets to market with pace, facilitatingresponsive strategic decision-making
- Create the right market conditions tooptimise demand for medicines at launch and beyond
- Leveragesimple, powerful ideas from complex data to continuously inform strategy and tactical optimisation
- Design the mostvaluable personalised customer experiencesusing innovations to drive a measurable change in behaviour and health outcomes
We have built a unique platform to challenge our clients to think and behave differently.
SEAMLESS EXPERTISE
We are uniquely configured to approach problems through the application of best-in-class functional expertise, ensuring every project has the optimal blend of experts working together seamlessly.
DESIGN-LED
We transform the way our clients develop solutions to today’s dynamic and multi-faceted healthcare problems. How? Through a human-centred creative design process that puts people’s needs, wants and capabilities at the centre of the solution.
OUTCOMES-DRIVEN
We reframe every objective and key strategic decision with the ambition to deliver meaningful outcomes that transform lives.
We are a diverse team of over 500 talented individuals deploying a flexible model to ensure we attract the best talent from across the UK, and across the world.
Beyond results to meaningful outcomes. Always.
- Contact details
- Jubilee House, Third Avenue, Globe Park, Marlow, Buckinghamshire, SL7 1EY United Kingdom
- 0345 0536671
- info@wearelucidgroup.com
- https://www.wearelucidgroup.com/
- Key contact
- Clare Reynolds
- Director of Commercial Strategy
- clare.reynolds@wearelucidgroup.com
- 07501989799
- 2022 Agency Data
-
2021 awardsTotal staff500-749 staffBillings from UK creative healthcare workHealthcare staff250-499 staffTotal agency billingsAgency ageBetween 15 and 20 yearsSocial media footprintStatusNETWORKEDApproximate percentage of advertising, branding, creative or design work in the UK healthcare market20-29%
- This information was supplied or confirmed by Lucid Group. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
- Awards
- 2021 COMMUNIQUÉ AWARDS:
WINNER, EXCELLENCE IN PUBLIC HEALTH
2021 COMMUNIQUÉ AWARDS:
WINNER, EXCELLENCE IN MEDICAL AFFAIRS
2021 PMEA AWARDS:
FINALIST, DIGITAL ANIMATION
2021 MM&M:
WINNER, BEST PLACES TO WORK - This may contain additional awards supplied by Lucid Group that were not included when generating this year’s T40 - please see methodology to find out which awards schemes were included.
Latest content from Lucid Group on PMHub
- My Lucid journey from PMW to Head of Medical
- Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced and demanding industry, but one which offers enviable flexibility, variety and intellectual challenge. Leading agency Lucid Group prides itself on the many growth and development opportunities it offers its people. In this article, Katherine Duxbury, Lucid’s Head of Medical, reflects upon her own bespoke working journey over the past 12 years and explains how creativity, collaboration and a passion for science have led to a rewarding, stimulating and self-curated career.
Lucid Group Communications Limited - Listen, learn and lift off
Lucid Group Communications Limited- Launch excellence
Lucid Group Communications Limited



COVID-19 Updates and Daily News
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- Highly competitive salary
Quick links
Latest intelligence
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Regeneron and Sonoma partner on autoimmune disease therapies
- Improving cardiovascular disease care and awareness
- PMGroup announces launch of new recruitment platform PharmaRole
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- The state of pharma customer experience
- MHRA to introduce new UK clinical trials framework
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children